Maroto JP

Language: Spanish
References: 14
Page: 49-51
PDF size: 154.07 Kb.

ABSTRACT

Age-related macula degeneration (AMD) is a progressive disease of the central part of the retina that is the leading cause of vision loss in people over the age of 50 years in the developed countries. The next paper is a bibliographic review of this pathology, its main features, diagnosis, classification and treatment.

REFERENCES

1. Age-Related Eye Disease Study Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology (Chicago, Ill.: 1960), 119(10), 1417- 1436.

2. Ambati, J., Atkinson, J. P., & Gelfand, B. D. (2013). Immunology of age-related macular degeneration. Nature Reviews. Immunology, 13(6), 438-451.

3. Ardeljan, D., & Chan, C.-C. (2013). Aging is not a disease: distinguishing age-related macular degeneration from aging. Progress in Retinal and Eye Research, 37, 68-89.

4. Chew, E. Y., Clemons, T., SanGiovanni, J. P., Danis, R., Domalpally, A., McBee, W., … Ferris, F. L. with AREDS2 Research Group. (2012). The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology, 119(11), 2282- 2289.

5. Hanout, M., Ferraz, D., Ansari, M., Maqsood, N., Kherani, S., Sepah, Y. J., … Nguyen, Q. D. (2013). Therapies for neovascular agerelated macular degeneration: current approaches and pharmacologic agents in development. BioMed Research International, 2013, 830837.

6. Holz, F. G., Schmitz-Valckenberg, S., & Fleckenstein, M. (2014). Recent developments in the treatment of age-related macular degeneration. The Journal of Clinical Investigation, 124(4), 1430-1438.

7. Jarrett, S. G., & Boulton, M. E. (2012). Consequences of oxidative stress in age-related macular degeneration. Molecular Aspects of Medicine, 33(4), 399-417.

8. Kanagasingam, Y., Bhuiyan, A., Abràmoff, M. D., Smith, R. T., Goldschmidt, L., & Wong, T. Y. (2014). Progress on retinal image analysis for age related macular degeneration. Progress in Retinal and Eye Research, 38, 20-42.

9. Parmeggiani, F., Sorrentino, F. S., Romano, M. R., Costagliola, C., Semeraro, F., Incorvaia, C., … Rubini, M. (2013). Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. Mediators of Inflammation, 2013, 435607.

10. Ratnapriya, R., & Chew, E. Y. (2013). Age-related macular degenerationclinical review and genetics update. Clinical Genetics, 84(2), 160-166.

11. Rhoades, W., Dickson, D., & Do, D. V. (2015). Potential role of lampalizumab for treatment of geographic atrophy. Clinical Ophthalmology (Auckland, N.Z.), 9, 1049-1056.

12. Schleicher, M., Weikel, K., Garber, C., & Taylor, A. (2013). Diminishing risk for age-related macular degeneration with nutrition: a current view. Nutrients, 5(7), 2405-2456.

13. Tokarz, P., Kaarniranta, K., & Blasiak, J. (2013). Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD). Biogerontology, 14(5), 461- 482.

14. Tranos, P., Vacalis, A., Asteriadis, S., Koukoula, S., Vachtsevanos, A., Perganta, G., & Georgalas, I. (2013). Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration. Drug Design, Development and Therapy, 7, 485-490.